Clindamycin / Lincosamides

Clindamycin is on this page for a reason that is mechanistic rather than spectral: toxin suppression. The toxic shock chapter states it directly: "Clindamycin should also be administered to suppress toxin production," and "penicillin is the preferred antibiotic for group A strep." The argument is worth understanding rather than memorizing. The killing in severe streptococcal disease is done by superantigen exotoxins that "bypass the normal pathway for activation of T cells," and a cell-wall agent that lyses organisms does not stop toxin that is already being made — a protein-synthesis inhibitor does. That is the entire case for adding a second drug to a penicillin-susceptible organism. Clindamycin appears in all three of the empiric necrotizing-infection regimens printed by the StatPearls chapter, at 600 to 900 mg four times daily — and those three regimens carry no named guideline owner, so they are the chapter's rather than IDSA's. Clindamycin has a second, unrelated role here: the beta-lactam-allergy alternative for mild cellulitis, 300 to 450 mg every 6 hours. Clostridioides difficile risk and the D-test belong to the class page.

A cause, not a cure. CDC lists clindamycin among the antibiotics most linked to CDI. If CDI develops, antibiotics not aimed at C. diff are reassessed and stopped or switched when safe.

A named alternative for susceptible organisms.

With gentamicin — first-line for postpartum endometritis. WHO: "A combination of clindamycin and gentamicin is recommended for the treatment of postpartum endometritis." StatPearls: IV clindamycin "(900 mg every 8 hours or 600 mg every 6 hours)" with gentamicin "is most effective." Also part of the necrotizing fasciitis regimen for toxin suppression (StatPearls, citing IDSA) and a second-line mastitis option (StatPearls, citing ABM).

Clindamycin has one sourced position on this page, and it is a narrow one: it is part of an alternative bite-wound regimen in penicillin allergy: doxycycline or trimethoprim-sulfamethoxazole plus metronidazole or clindamycin, where its role is the anaerobic coverage that the partner agent lacks. It is a substitution rather than a first choice, which is worth stating plainly because an allergy label frequently drives a reflex switch without anyone checking whether the allergy is real or what is being covered. The disorder-side logic is the flora: bite wounds carry anaerobes, and whichever backbone replaces amoxicillin-clavulanate has to account for them. Clindamycin pharmacology, and in particular its association with Clostridioides difficile infection, belongs to the class page — as does the broader point that every unnecessary broad-spectrum exposure feeds the resistance pattern now being seen in surgical site infections.

The original β-lactams — bactericidal cell-wall inhibitors. The defining nursing job is screening for and recognizing allergy, from rash to anaphylaxis.

β-lactam cousins of penicillin, organized by generation — each generation trades some gram-positive reach for broader gram-negative coverage.

Powerful, broad-spectrum DNA-synthesis blockers — but a boxed warning for disabling tendon, nerve, and CNS effects means they’re reserved when alternatives exist.

Suppress viral replication rather than kill viruses outright. The nursing essentials: hydrate with acyclovir, start early (flu within 48 h), and remember most antivirals suppress — they don’t cure.

Powerful IV drugs for serious Gram-negative infection — but nephrotoxic and ototoxic. Levels matter.

Broad, generally safe protein-synthesis inhibitors — a penicillin-allergy alternative. Watch QT and CYP3A4.